Swiss F-35 Review Adds to LMT's Uncertainties

What happened

Lockheed Martin's F-35 program faces fresh uncertainty as Switzerland reviews its $7.6 billion deal, adding to the headwinds of negative free cash flow and program charges already weighing on the stock. The news does not alter Lockheed's fundamental cash conversion challenges, which drove negative FCF in 1Q26 and remain the primary near-term risk. Switzerland is a single customer, but the review signals potential delays or cancellations in international F-35 orders, which could pressure backlog conversion and international segment revenues. This development increases the probability of the Bear case (implied value $430) in the DeepValue framework, where weaker cash generation and additional program losses materialize. Investors should monitor the Swiss review outcome and await evidence of cash normalization before adding to positions.

Implication

The Swiss F-35 uncertainty is an incremental negative but not a thesis breaker; focus remains on Lockheed's ability to reverse negative free cash flow and contain program losses. A material Swiss cancellation could lower international revenue visibility, but the stock's valuation already reflects headwinds. The WAIT rating is maintained, with a re-assessment window of 3-6 months pending cash conversion evidence.

Thesis delta

The Swiss F-35 review adds to international order risk, modestly increasing the probability of the Bear scenario (30% to 35%) where cash conversion stays weak. This does not change the core thesis that near-term returns depend on cash normalization and program execution, not headlines, but it amplifies the need for visible working capital reversal in the next two quarters.